Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases

Piotr Eder; Michał Łodyga; Agnieszka Dobrowolska; Jarosław Reguła; Grażyna Rydzewska

doi:10.5114/pg.2021.103666

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

1/2021
vol. 16

Send email

Copy url:

abstract:

Guidelines/recommendations

Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases

Piotr Eder

¹

,

Michał Łodyga

²

,

Agnieszka Dobrowolska

³

,

Jarosław Reguła

³

,

Grażyna Rydzewska

^{2, 4}

Chair and Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, Swiecicki Clinical Hospital, Poznan, Poland

Department of Internal Diseases and Gastroenterology with Subdivision for the Treatment of Non-Specific Inflammatory Bowel Diseases, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland

Department of Gastroenterological Oncology, Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Collegium Medicum, Jan Kochanowski University, Kielce, Poland

Gastroenterology Rev 2021; 16 (1): 2–4

DOI: https://doi.org/10.5114/pg.2021.103666

Online publish date: 2021/02/15

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Eder P, Łodyga M, Dobrowolska A, Reguła J, Rydzewska G. Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases. Gastroenterology Review/Przegląd Gastroenterologiczny. 2021;16(1):2-4. doi:10.5114/pg.2021.103666.

APA

Eder, P., Łodyga, M., Dobrowolska, A., Reguła, J.,  & Rydzewska, G. (2021). Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases. Gastroenterology Review/Przegląd Gastroenterologiczny, 16(1), 2-4. https://doi.org/10.5114/pg.2021.103666

Chicago

Eder, Piotr, Michał Łodyga, Agnieszka Dobrowolska, Jarosław Reguła,  and Grażyna Rydzewska. 2021. "Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases". Gastroenterology Review/Przegląd Gastroenterologiczny 16 (1): 2-4. doi:10.5114/pg.2021.103666.

Harvard

Eder, P., Łodyga, M., Dobrowolska, A., Reguła, J.,  and Rydzewska, G. (2021). Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases. Gastroenterology Review/Przegląd Gastroenterologiczny, 16(1), pp.2-4. https://doi.org/10.5114/pg.2021.103666

MLA

Eder, Piotr et al. "Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 16, no. 1, 2021, pp. 2-4. doi:10.5114/pg.2021.103666.

Vancouver

Eder P, Łodyga M, Dobrowolska A, Reguła J, Rydzewska G. Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases. Gastroenterology Review/Przegląd Gastroenterologiczny. 2021;16(1):2-4. doi:10.5114/pg.2021.103666.

PlumX metrics:

The COVID-19 (coronavirus disease 2019) pandemic significantly impacted the functioning of the whole world, both with regard to health, society, and economics. It is the greatest civilizational challenge for humanity since World War II. So far, more than 80 million SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) infections have been reported, and nearly 2 million people have died from this infectious disease (as of 4.01.2021) [1]. However, accurate statistics on the number of patients in whom infection did not lead to death but caused significant organ complications are unknown. The long-term effects of infection with the new coronavirus species also remain unelucidated.

Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases

Piotr Eder 1 , Michał Łodyga 2 , Agnieszka Dobrowolska 3 , Jarosław Reguła 3 , Grażyna Rydzewska 2, 4

Piotr Eder

¹

,

Michał Łodyga

²

,

Agnieszka Dobrowolska

³

,

Jarosław Reguła

³

,

Grażyna Rydzewska

^{2, 4}